Tests Related to Pregnancy 

 

Nuchal Translucency

The USA Center for Women's Health is the first in Alabama certified to provide this leading-edge early detection screening. It is approximately 80% accurate in detecting Down syndrome and other chromosomal defects. Combined with a simple blood test, doctors can detect more than 90% of patients at risk for Down syndrome and 97% of those at risk for Trisomy-18.

The test is non-invasive, using ultrasound technology to make precise measurements of the anatomy of the developing fetus. As a result, the risks associated with traditional invasive tests - amniocentesis and chorionic villi - are avoided. Miscarriages occur in 1 in every 200 amniocentesis; 1 in every 100 chorionic villi samples.

The test is conducted between 10 and 13 weeks gestation, providing doctors and patients early data on risk factors for the developing baby. 

 

Fetal Fibronectin

A test similar to a Pap smear looks for the presence of this protein and determines whether a woman is experiencing premature labor. Testing is completed onsite at USA Children's and Women's Hospital - providing lab results within two hours and appropriate medical intervention if indicated.

 

Email Newsletters

Connect With Us